this post was submitted on 15 Oct 2024
14 points (88.9% liked)

Futurology

1731 readers
130 users here now

founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
[–] PennyRoyal@sh.itjust.works 5 points 17 hours ago (2 children)

Is it speed? It’s speed, isn’t it?

[–] m4xie@lemmy.blahaj.zone 1 points 4 hours ago

It's working great for me, but I definitely have ADHD

[–] MeowZedong@lemmygrad.ml 1 points 17 hours ago

Looks like it's a monoclonal antibody design to decrease inflammation. The target is people with persistent, low levels of inflammation and major depression.

My institution doesn't give access, but my first question would be whether they accounted for treatment for the underlying cause of the inflammation. Persistent inflammation can cause all sorts of issues and I suppose a treatment for relief is good, but why does it exist? Treating the underlying condition seems more prudent unless they don't know the cause.